These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24026740)

  • 1. Reduction in Parkinson's disease therapy improved punding but not feeling of presence.
    Aquino CC; Celso de Castro P; Doná F; Medeiros L; Silva SM; Borges V; Ferraz HB
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E43-4. PubMed ID: 24026740
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperthyroidism "masked" the levodopa response in newly diagnosed Parkinson's disease patients.
    Prakash KM; Kek PC
    Parkinsonism Relat Disord; 2010 Dec; 16(10):691-2. PubMed ID: 20729126
    [No Abstract]   [Full Text] [Related]  

  • 3. Bupropion abates dopamine agonist-mediated compulsive behaviors in Parkinson's disease.
    Benincasa D; Pellicano C; Fanciulli A; Pontieri FE
    Mov Disord; 2011 Feb; 26(2):355-7. PubMed ID: 21412840
    [No Abstract]   [Full Text] [Related]  

  • 4. Zoophilia and Parkinson's disease.
    Almeida KJ; de Oliveira Filho MC; Lopes Nery PC; Guimarães Silva JS; Campos Sousa RN
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1167-8. PubMed ID: 23973014
    [No Abstract]   [Full Text] [Related]  

  • 5. Compulsive singing: another aspect of punding in Parkinson's disease.
    Bonvin C; Horvath J; Christe B; Landis T; Burkhard PR
    Ann Neurol; 2007 Nov; 62(5):525-8. PubMed ID: 17696122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
    Ávila A; Cardona X; Martín-Baranera M; Bello J; Sastre F
    J Neurol Sci; 2011 Nov; 310(1-2):197-201. PubMed ID: 21683375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy of Parkinson's disease].
    Zhou XD
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):193-6. PubMed ID: 4075905
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benefits of a new galenic form of levodopa and benserazide in the treatment of patients with Parkinson disease].
    Dessibourg CA; Gachoud JP
    Praxis (Bern 1994); 1995 Oct; 84(43):1235-8. PubMed ID: 7481341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Punding prevalence in Parkinson's disease.
    Miyasaki JM; Al Hassan K; Lang AE; Voon V
    Mov Disord; 2007 Jun; 22(8):1179-81. PubMed ID: 17230464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compulsive sexual behaviour in Parkinson's disease is associated with higher doses of levodopa.
    Barbosa PM; Grippe T; Lees AJ; O'Sullivan S; Djamshidian A; Warner TT
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1121-1123. PubMed ID: 29175897
    [No Abstract]   [Full Text] [Related]  

  • 11. Levodopa dependence and abuse in Parkinson's disease.
    Spigset O; von Schéele C
    Pharmacotherapy; 1997; 17(5):1027-30. PubMed ID: 9324193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benefits of the combination of mucuna, green tea and levodopa/benserazide in Parkinson's disease].
    Gonzalez-Maldonado R; Gonzalez-Redondo R; Di Caudo C
    Rev Neurol; 2016 Jun; 62(11):524-6. PubMed ID: 27222087
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of Parkinson's disease. Practical criteria of treatment].
    Casacchia M; Carolei A; Zamponi A; Agnoli A; Fazio C
    Recenti Prog Med; 1976 May; 60(5):567-84. PubMed ID: 14360
    [No Abstract]   [Full Text] [Related]  

  • 14. Clozapine as a potential treatment for refractory impulsive, compulsive, and punding behaviors in Parkinson's disease.
    Hardwick A; Ward H; Hassan A; Romrell J; Okun MS
    Neurocase; 2013; 19(6):587-91. PubMed ID: 22934916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Motor fluctuations in Parkinson's disease: the "New frontier" of therapeutic success. A Roche Laboratory seminar].
    d'Anglejan Chatillon J
    Rev Prat; 1989 Mar; 39(8):689-90. PubMed ID: 2727575
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolated delusional syndrome in Parkinson's Disease.
    Stefanis N; Bozi M; Christodoulou C; Douzenis A; Gasparinatos G; Stamboulis E; Stefanis C; Stefanis L
    Parkinsonism Relat Disord; 2010 Sep; 16(8):550-2. PubMed ID: 20620094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration-effect relationship of levodopa-benserazide dispersible formulation versus standard form in the treatment of complicated motor response fluctuations in Parkinson's disease.
    Contin M; Riva R; Martinelli P; Cortelli P; Albani F; Baruzzi A
    Clin Neuropharmacol; 1999; 22(6):351-5. PubMed ID: 10626097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural tremor of Parkinson's disease.
    Henderson JM; Yiannikas C; Morris JG; Einstein R; Jackson D; Byth K
    Clin Neuropharmacol; 1994 Jun; 17(3):277-85. PubMed ID: 9316673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
    Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
    Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Parkinson's disease in a patient with acute intermittent porphyria.
    Gorchein A
    Br J Clin Pharmacol; 1995 Jul; 40(1):105-6. PubMed ID: 8527261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.